QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk

QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share.
Open original source
QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share.
Open original source